Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/23585
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGravas, Stavros-
dc.contributor.authorFournier, Georges-
dc.contributor.authorOya, Mototsugu-
dc.contributor.authorSummerton, Duncan-
dc.contributor.authorScarpa, Roberto Mario-
dc.contributor.authorChlosta, Piotr-
dc.contributor.authorGkialas, Ioannis-
dc.contributor.authorXie, Li-Ping-
dc.contributor.authorRasyid, Nur-
dc.contributor.authorBolton, Damien M-
dc.contributor.authorGomez, Reynaldo-
dc.contributor.authorKlotz, Laurence-
dc.contributor.authorKulkarni, Sanjay-
dc.contributor.authorTanguay, Simon-
dc.contributor.authorde la Rosette, Jean-
dc.date2020-06-15-
dc.date.accessioned2020-06-30T04:09:51Z-
dc.date.available2020-06-30T04:09:51Z-
dc.date.issued2020-06-15-
dc.identifier.citationEuropean urology focus 2020; online first: 15 June-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23585-
dc.description.abstractDetermining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations. To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations. Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d'Urologie. Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively. There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents' priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers. Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings. When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources.-
dc.language.isoeng-
dc.subjectCOVID-19-
dc.subjectCoronavirus-
dc.subjectGuidelines-
dc.subjectPandemic-
dc.subjectPractice management-
dc.subjectSevere acute respiratory syndrome coronavirus 2-
dc.subjectUrology-
dc.titlePrioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines.-
dc.typeJournal Article-
dc.identifier.journaltitleEuropean urology focus-
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece-
dc.identifier.affiliationDepartment of Urology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Hopital de la Cavale Blanche, University of Brest, Brest, France-
dc.identifier.affiliationDepartment of Urology, Keio University School of Medicine, Tokyo, Japan-
dc.identifier.affiliationDepartment of Urology, University Hospitals of Leicester NHS Trust, Leicester, UK-
dc.identifier.affiliationDepartment of Urology, Università Campus Biomedico, Rome, Italy-
dc.identifier.affiliationDepartment of Urology, Jagiellonian University-Medical College, Krakow, Poland-
dc.identifier.affiliationDepartment of Urology, Anticancer Hospital of Athens "Agios Savvas", Athens, Greece-
dc.identifier.affiliationDepartment of Urology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China-
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia-
dc.identifier.affiliationUniversidad Andres Bello, Hospital del Trabajador, Santiago, Chile-
dc.identifier.affiliationDivision of Urology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada-
dc.identifier.affiliationKulkarni Reconstructive Urology Center, Pune, India-
dc.identifier.affiliationDepartment of Surgery, Division of Urology, McGill University, Montreal, QC, Canada-
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey-
dc.identifier.doi10.1016/j.euf.2020.06.006-
dc.identifier.orcid0000-0002-5145-6783-
dc.identifier.pubmedid32571743-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.